The digital health boom slows in Q1 2022—but investors continue to place bets on high ROI areas, such as fertility

Posted On // Leave a Comment
 
Insider Intelligence
 

The digital health boom slows in Q1 2022—but investors continue to place bets on high ROI areas, such as fertility

Digital health funding reached $6 billion across 183 deals during Q1 of 2022, falling behind Q4 2021 ($7.3 billion), according to a report by Rock Health. This decline in investment is likely due in part to geopolitical tensions, inflation, and fewer SPAC deals.

Despite this digital health slowdown, fertility remains a sweet spot for investors, as reproductive health startups become one of the top six most funded treatment areas, after securing $424 million last quarter.

Looking ahead, we expect that startups that can personalize fertility will climb even higher on the top-funded list, as patient-centered care can lower the cost for patients in the long run and offset the high cost of treatments. What's more, 83% of healthcare consumers are already using digital health tools to track their fertility, per Rock Health. "Which means there is high consumer awareness and interest in fertility tech," said Rhea Ahmed, analyst at Insider Intelligence.

Read This Full Story on Insider Intelligence
 

Related articles

 
Walmart opens 5 new clinics in Florida with same approach of low costs and convenience as its Supercenters
View Article
Pear Therapeutics launches new program to improve digital patient access to addiction treatment
View Article
 

Thanks for Reading!

Find out why more than 100,000 corporate subscribers worldwide trust our unbiased approach to make grounded decisions about the future of their business.

Become a Client
 
 

Email sent to: nguyenvu1187.love5@blogger.com

Manage your email preferences  |  Unsubscribe  |  Terms of Service  |  Privacy Policy
 

© 2022 Insider Intelligence, 11 Times Square, New York, NY 10036

 
Powered By SailthrU
                                                           

0 comments:

Post a Comment